Centocor Patents Stand In Fight Over Abbott's Humira
A federal judge has refused Abbott Laboratories' bid to invalidate two patents in an infringement suit brought by Centocor Inc. and New York University over Abbott's flagship arthritis drug Humira....To view the full article, register now.
Already a subscriber? Click here to view full article